Apolipoprotein E Gene Variation in Pakistani Subjects with Type 2 Diabetes with and without Cardiovascular Complications

被引:1
|
作者
Nadeem, Shehwar [1 ]
Maqbool, Tahir [1 ]
Qureshi, Javed Anver [1 ]
Altaf, Awais [1 ]
Naz, Sadia [2 ]
Azhar, Muzammal Mateen [2 ]
Ullah, Inam [1 ]
Shah, Tawaf Ali [3 ]
Qamar, Muhammad Usman [4 ,5 ]
Salamatullah, Ahmad Mohammad [6 ]
机构
[1] Univ Lahore, Ctr Res Mol Med, Inst Mol Biol & Biotechnol, Lahore 54660, Pakistan
[2] Univ Lahore, Dept Allied Hlth Sci, Lahore 54660, Pakistan
[3] Shandong Univ Technol, Coll Agr Engn & Food Sci, Zibo 255049, Peoples R China
[4] Univ Geneva, Dept Med, Div Infect Dis, CH-1211 Geneva, Switzerland
[5] Govt Coll Univ Faisalabad, Fac Life Sci, Inst Microbiol, Faisalabad 38000, Pakistan
[6] King Saud Univ, Coll Food & Agr Sci, Dept Food Sci & Nutr, Riyadh 11451, Saudi Arabia
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 06期
关键词
apolipoprotein E; polymorphisms; ischemic heart disease; stroke; MELLITUS; DYSLIPIDEMIA; EPIDEMIOLOGY; RISK; ASSOCIATION; PREVALENCE; DISEASE;
D O I
10.3390/medicina60060961
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Apolipoprotein E (APOE) gene polymorphism has been implicated in the pathogenesis of various metabolic disorders, including type 2 diabetes mellitus (T2DM). Type 2 diabetes mellitus (T2DM) is a major public health concern worldwide, including in Pakistan. Cardiovascular problems linked with T2DM have a significant impact on individuals and society. The goal of this study is to investigate the relationship between Apolipoprotein E (ApoE) genotypes, dyslipidemia, and cardiovascular complications such as ischemic heart disease (IHD) and stroke. Methods: This study was carried out on 260 subjects divided into controls and diabetics. The diabetics were further divided into four subgroups such as D1: diabetics without cardiovascular issues, D2: diabetics with heart disease, D3: diabetics with stroke, and D4: diabetics with both heart disease and stroke. Anthropometric parameters (age, BMI) and risk factors (smoking, diabetes duration, hypertension) were assessed in all groups. Serum levels of TC, TG, LDL, HDL, VLDL, creatinine, BSF, and HbA1c were also measured. Apolipoprotein E gene polymorphism was determined using PCR-RFLP. Results: Hypertension, BMI, and dyslipidemia are defined as elevated levels of total cholesterol, triglycerides, LDL, and VLDL, and decreased levels of HDL. Uncontrolled hyperglycemia (elevated fasting blood sugar and glycated hemoglobin) in T2DM was linked to vascular complications such as IHD and stroke. Hypertension was prevalent in 79.3% of the population. Stage 2 hypertension was more prevalent in all age groups. It was also noted that common genotypes in the Pakistani population are 3/3, 4/4, 2/3, and 3/4. The frequency of genotypes 3/4 and 2/3 is highest in diabetics with stroke. Genotype 3/3 is present frequently in diabetics with IHD/stroke and patients with both these complications. However, genotype 4/4 is most frequently found in diabetics with IHD. Conclusions: It is concluded that BMI, hypertension, hyperglycemia, atherosclerosis, and dyslipidemia are linked with cardiovascular complications of type 2 diabetes. Apolipoprotein E gene polymorphism is associated with cardiovascular disease in patients with diabetes by affecting the lipid profile.
引用
收藏
页数:23
相关论文
共 50 条
  • [41] Platelet-Derived NO in Subjects Affected by Type 2 Diabetes with and without Complications: Is there any Relationship with their Offspring?
    Sabbatinelli, Jacopo
    Vignini, Arianna
    Salvolini, Eleonora
    Nanetti, Laura
    Mazzanti, Laura
    Rabini, Rosa Anna
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2017, 125 (05) : 290 - 296
  • [42] Lipid profile variation in type 2 diabetes mellitus in Tunisian patients with and without cardiovascular diseases
    Khlifi, S.
    Ben Ahmed, H.
    Hafiane, A.
    Abaza, H.
    Serairi, R.
    Abid, A.
    Guemira, F.
    Belhani, A.
    Aouidet, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 4 - 4
  • [43] Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36)
    Yokoyama, H.
    Araki, S.
    Kawai, K.
    Hirao, K.
    Oishi, M.
    Sugimoto, K.
    Sone, H.
    Maegawa, H.
    Kashiwagi, A.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (03) : 485 - 492
  • [44] Apolipoprotein E promoter polymorphisms and glomerulopathy in type 2 diabetes
    Geng, Hua
    Zhao, Hai-Lu
    Ng, Ho-Keung
    Lai, Fernand Macmoune
    Tong, Peter Chun-Yip
    Chan, Juliana Chung-Ngor
    Ho, Yuan-Yuan
    DIABETES, 2006, 55 : A178 - A178
  • [45] P-selectin gene genotypes or haplotypes and cardiovascular complications in type 2 diabetes mellitus
    Zalewski, G.
    Ciccarone, E.
    Di Castelnuovo, A.
    Zito, F.
    Capani, F.
    de Gaetano, G.
    Donati, M. B.
    Iacoviello, L.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 (06) : 418 - 425
  • [46] CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial
    Dolores Corella
    Eva. M. Asensio
    Oscar Coltell
    José V. Sorlí
    Ramón Estruch
    Miguel Ángel Martínez-González
    Jordi Salas-Salvadó
    Olga Castañer
    Fernando Arós
    José Lapetra
    Lluís Serra-Majem
    Enrique Gómez-Gracia
    Carolina Ortega-Azorín
    Miquel Fiol
    Javier Díez Espino
    Andrés Díaz-López
    Montserrat Fitó
    Emilio Ros
    José M. Ordovás
    Cardiovascular Diabetology, 15
  • [47] CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial
    Corella, Dolores
    Asensio, Eva M.
    Coltell, Oscar
    Sorli, Jose V.
    Estruch, Ramon
    Martinez-Gonzalez, Miguel Angel
    Salas-Salvado, Jordi
    Castaner, Olga
    Aros, Fernando
    Lapetra, Jose
    Serra-Majem, Lluis
    Gomez-Gracia, Enrique
    Ortega-Azorin, Carolina
    Fiol, Miquel
    Diez Espino, Javier
    Diaz-Lopez, Andres
    Fito, Montserrat
    Ros, Emilio
    Ordovas, Jose M.
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [48] Associations between Apolipoprotein E Gene Polymorphisms and Cardiovascular Complications of Uremic Patients on Maintenance Hemodialysis
    Zheng, Chang-Zhi
    Qi, Xiang-Ming
    Shu, Yong-Bing
    Bai, You-Wei
    Wu, Yong-Gui
    BLOOD PURIFICATION, 2018, 46 (01) : 48 - 55
  • [49] Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot
    Pinto, Antonio
    Tuttolomondo, Antonino
    Di Raimondo, Domenico
    Fernandez, Paola
    La Placa, Sergio
    Di Gati, Maria
    Licata, Giuseppe
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2008, 57 (05): : 676 - 682
  • [50] Cardiovascular complications and drug prescriptions in subjects with and without diabetes in a Northern region of Italy, in 2002 and 2012
    Baviera, M.
    Avanzini, F.
    Marzona, I.
    Tettamanti, M.
    Vannini, T.
    Cortesi, L.
    Fortino, I.
    Bortolotti, A.
    Merlino, L.
    Trevisan, R.
    Roncaglioni, M. C.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2017, 27 (01) : 54 - 62